All Articles

A hidden crisis is cleaving the tech world in two. As AI giants consume the global supply of advanced chips, everyone else faces a growing famine.

A new drug from Cambrian Bio shows promise in activating a key metabolic switch. This could lead to treatments that burn fat while preserving muscle mass.

Shokz's partnership with the Western States 100 isn't just a sponsorship; it's a masterclass in niche marketing. We deconstruct why a market-dominant brand is betting on 369 runners.

A new UN-nonprofit partnership aims to transform methane monitoring from a passive exercise into a rapid response system, targeting oil and gas super-emitters.

A new app from a Siri co-founder is embedding intelligent AR characters into our messages. But is this the future of connection or just a novel distraction?

Career colleges are booming as students flee AI, yet face intense pressure to adopt it. A new firm claims its bespoke approach can deliver massive ROI without the chaos.

Industrial arm maker INLIF is jumping into the humanoid race. But can a small firm with unverified claims compete with giants like Boston Dynamics and Tesla?

With nearly 1 in 4 students chronically absent, schools are losing funds and students are falling behind. A new tech wave aims to replace truancy letters with data-driven partnership.

A health AI company is adding top cardiologists to its board, signaling a strategic shift to prove that algorithms can solve real-world health crises.

With Hillary Aiken leading its new philanthropic arm, 23andMe Research Institute bets on private giving to accelerate its 'public good' DNA revolution.

FIS’s clean sweep in Chartis’s risk quadrants isn't just an award; it’s a signal that integrated risk management is now table stakes for competitive advantage.

As AI moves beyond hype, Gartner spotlights Zyter's work in healthcare, proving that governance and orchestration are key to unlocking real-world value.

The 2026 StreamTV Awards reveal a shift toward advanced ad tech, strategic partnerships, and user-centric design, with Roku and Xumo dominating key categories.

Alight's 1-for-20 reverse split aims to save its NYSE listing. Is this a savvy strategic reset or a temporary fix for a stock facing deeper challenges?

As AI gets more powerful, the human user is becoming the bottleneck. A new class of 'Super-Sub' AI assistants aims to fix this by streamlining our workflow.

Beyond simple comfort, your next HVAC is a major investment. We break down the tech, costs, and policies shaping the heat pump, furnace, and hybrid debate.

Opodo's latest data reveals more than just destinations; it shows a strategic consumer shift. Brits are trading long-haul for value and impulse for planning.

New detachable sensor leads from Monnit allow for instant recertification, eliminating costly downtime in pharma and healthcare while ensuring data integrity.

A court ruling clears the way for Curium's targeted cancer drug, promising new hope for patients and shaking up the multi-billion-dollar radiopharmaceutical market.

A new report reveals a startling trend: as AI adoption soars, financial firms are increasingly banning communication channels, a defensive move creating new risks.